课题基金 / 基金详情

Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: A Pilot Randomized Controlled Trial - CONQUER-DVT Pilot Trial

Colchicine to Quench the Inflammatory Response after Deep Vein Thrombosis: A Pilot Randomized Controlled Trial - CONQUER-DVT Pilot Trial
秋水仙碱可减轻深静脉血栓形成后的炎症反应：一项随机对照试验 - CONQUER-DVT 试验
批准号：
480053
负责人：
Carrier Marc
金额：
$27.31万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2026-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=480053&lang=en
关键词：
Clotting Defects/Thrombosis Colchicine Deep Vein Thrombosis Inflammation Pilot Study Post Thrombotic Syndrome Randomized Controlled Trial Venous Thromboembolism

项目摘要

项目成果

Carrier Marc的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Inflammation defends the human body against invading microbes. The formation of blood clots in the veins of the leg (deep vein thrombosis) causes undesired inflammation leading to harmful consequences. As a result, almost one in two people experiences the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Primary thromboprophylaxis with rivaroxaban in patients with malignancy and central venous catheters: TRIM-Line.
  • 批准号：
    434579
  • 项目类别：
    Operating Grants
  • 资助金额：
    $100.81万
  • 财政年份：
    2020
  • 负责人：
    Carrier Marc
  • 依托单位：
    Ottawa Hospital Research Institute
The Use of Extended Peri-operative Low Molecular Weight Heparin to Improve Cancer Specific Survival Following Surgical Resection of Colon Cancer: A Randomized Controlled Trial
  • 批准号：
    200970
  • 项目类别：
    Operating Grants
  • 资助金额：
    $59.46万
  • 财政年份：
    2010
  • 负责人：
    Carrier Marc
  • 依托单位：
    Ottawa Hospital Research Institute
Screening for Previously Undiagnosed Cancer in Patients with Venous Thromboembolism
  • 批准号：
    178854
  • 项目类别：
    Randomized Controlled Trials
  • 资助金额：
    $10.2万
  • 财政年份：
    2009
  • 负责人：
    Carrier Marc
  • 依托单位：
    University of Ottawa
海外基金